Inflammasome Complex Formation and Canonical Functions
Inflammasomes are large multimolecular complexes best known for their ability to control activation of the proteolytic enzyme caspase-1 (Martinon et al., 2002) . Caspase-1 in turn regulates the proteolytic maturation of interleukin-1b and IL-18, as well as a rapid, noxious, inflammatory form of cell death termed pyroptosis (Rathinam et al., 2012a) . Assembly of inflammasome complexes is dependent on cytosolic sensing of pathogen-associated molecular patterns that gain access to the cytosol during microbial infection. In addition, endogenous danger signals (danger-associated molecular patterns) released from damaged or dying cells also activate inflammasomes and drive pathological inflammation in sterile inflammatory diseases, including atherosclerosis, Alzheimer's disease, diabetes, and cancer (Latz et al., 2013) .
Several distinct inflammasomes have been identified, each differentiated by unique activators, NLR/ALR family members, and caspase effectors. The classical or canonical inflammasome complex consists of a cytosolic sensor (which can be either a nucleotide-binding domain and leucine-rich-repeat-containing [NLR] protein or an AIM2-like receptor [ALR] protein), an adaptor protein (apoptosis-associated speck-like protein containing a CARD [ASC] ), and an effector caspase pro-caspase-1 (von Moltke et al., 2013) . ASC is a bipartite molecule that contains both an N-terminal Pyrin domain (PYD) and a C-terminal caspase activation and recruitment domain (CARD), enabling it to bridge the sensors (NLRs or ALRs) and the effector pro-caspase-1. Pro-caspase-1 is subsequently activated leading to the cleavage of pro-IL-1b and pro-IL-18 and the generation of the mature biologically active cytokines. Direct versus Indirect Activation of the Inflammasome Depending on the NLR/ALR within the complex, inflammasomes are equipped with the ability to respond to a wide array of signals.
Some of these signals act as direct ligands for NLR/ALR proteins and bind them, leading to their oligomerization and activation. The NLR apoptosis inhibitory protein (NAIP)/NLRC4 inflammasome directly recognizes bacterial flagellin and type III secretion system components (Kofoed and Vance, 2011; Zhao et al., 2011) . In the case of AIM2, direct binding of double-stranded DNA leads to inflammasome complex formation (Fernandes-Alnemri et al., 2009; Hornung et al., 2009; Roberts et al., 2009) . Another ALR protein, IFI16, can also bind DNA and engage ASC, leading to inflammasome activation (Kerur et al., 2011) . IFI16 sensing of DNA and inflammasome-dependent pyroptosis is critical during HIV infections as it contributes to the depletion of abortively infected CD4 T cells in lymphoid tissues and consequently immunosuppression (Monroe et al., 2014) . On the other hand, certain inflammasomes respond to cellular perturbations associated with microbial infections and tissue damage. Recently, the Pyrin inflammasome was shown to employ a novel mechanism to recognize bacterial infections. In this system, Pyrin detects bacterial modification of Rho GTPases. Various modifications of Rho GTPases, namely glucosylation, adenylylation, ADP-ribosylation, and deamidation at different amino acid residues by bacterial toxins such as Clostridium difficile TcdB and Clostridium botulinum C3, activate the Pyrin inflammasome (Xu et al., 2014) . The NLRP3 inflammasome responds to a multitude of signals of diverse physicochemical nature (e.g., ATP, potassium ionophores, particulate matters, etc.) (Latz et al., 2013) . However, the exact mechanism(s) by which NLRP3 is activated by these diverse ligands is surprisingly still unclear. There is no evidence that NLRP3 binds directly to any of its diverse activators. Although it has been shown that known NLRP3 stimuli converge on potassium ion efflux upstream of NLRP3 activation (Muñ ozPlanillo et al., 2013) , the exact molecular mechanism of NLRP3 activation still remains elusive.
A Role for Nek7 in NLRP3 Inflammasome Activation Very recently a new kinase Nek7 was identified as a central regulator of the NLRP3 inflammasome. Nek7 is a serine-threonine kinase previously known to be involved in mitosis. A genome-wide CRISPR/Cas9 screen in mouse macrophages found that the loss of Nek7 protected cells from nigericin-induced pyroptosis (Schmid-Burgk et al., 2016) . Similarly, a forward genetic screen employing N-ethyl-N-nitrosourea in C57BL/6J mice revealed that deficiency in Nek7 abolished nigericin-induced IL-1b secretion by macrophages (Shi et al., 2015) . Confirming these two genetic screens, a proteomic analysis of NLRP3-binding proteins using mass spectrometry identified Nek7 as an NLRP3-interacting protein (He et al., 2016) . In response to NLRP3 activators such as nigericin and ATP, NEK7 interacts with the leucine-rich repeat domain of NLRP3 and forms a high-molecular-weight complex with NLRP3, facilitating ASC and caspase-1 oligomerization. However, the kinase activity of Nek7 was dispensable for the activation of NLRP3. In vivo, Nek7 promoted the NLRP3-dependent cellular inflammatory response to monosodium urate crystals and the development of experimental autoimmune encephalitis in mice (He et al., 2016; Shi et al., 2015) . These findings indicate that NEK7 represents a central hub upstream of NLRP3. Exactly how Nek7 is enlisted into the inflammasome pathway, however, is still an unresolved question.
Additional Caspases and Gasdermin D in Inflammasome Signaling
In addition to the canonical mode of inflammasome activation, additional caspases such as caspase-8 or caspase-11 (caspase 4/5 in humans) also contribute to inflammasome-dependent control of IL-1b/IL18 processing and pyroptotic cell death. Caspase-8 is engaged downstream of several pathways, including those triggered by dectin-1, Fas ligand, chemotherapeutic drugs, dsRNA engagement of TLR3, as well as certain classical activators of the NLRP3 inflammasome, where caspase-8 appears to serve a scaffolding function (Bossaller et al., 2012; Ganesan et al., 2014; Gurung et al., 2014; Karki et al., 2015; Lukens et al., 2014) Although caspase-8 can function as an IL-1b converting enzyme in certain contexts, in many of these cases, caspase-8 interacts with the NLRP3 inflammasome to modulate inflammasome effector functions (Man et al., 2013) . Importantly, considerable progress in recent years has defined a non-canonical inflammasome pathway involving caspase-11, a caspase-1-like inflammatory protease (Kayagaki et al., 2011) . Caspase-11 functions as a central regulator of non-canonical inflammasome activity during infection with Gram-negative bacterial pathogens that signal via NLRP3 (Rathinam et al., 2012b) . Gram-negative bacterial pathogens require a licensing signal to facilitate NLRP3-dependent caspase-1 activation, cytokine maturation, and pyroptotic cell death. This licensing signal involves transcriptional induction of caspase-11 and guanylate-binding proteins (GBPs) via TLR4-TRIF-type I IFN signaling (Broz et al., 2012; Gurung et al., 2012; Rathinam et al., 2012b) . It is likely that additional interferon-stimulated genes also contribute to these events. Studies over the last few years have also revealed that lipopolysaccharide (LPS) from Gram-negative bacteria gains to access to the cytosol and signals independently of TLR4 by binding directly to caspase-11 (Hagar et al., 2013; Kayagaki et al., 2013; Shi et al., 2014) . LPS binding to casapse-11 activates casapse-11 proteolytic activity, leading to caspase-1-dependent IL-1b processing as well as a casapse-1-independent pyroptotic cell death. Latest developments in this area have shown that caspase-11 activation by intracellular LPS leads to cleavage of a new substrate protein, gasdermin D. The resulting amino-terminal cleavage fragment of gasdermin D controls NLRP3-dependent activation of caspase-1 and the demise of the cell via pyroptosis (He et al., 2015; Kayagaki et al., 2015; Shi et al., 2015) . Collectively, all of these findings reveal that there are different modes of inflammasome activation. In the case of NLRP3, there is both a canonical and non-canonical route of activation, each of which involves distinct inflammatory caspases. A schematic highlighting these advances in NLRP3 inflammasome signaling is shown in Figure 1 . Critical Role of Type I Interferon Signaling in Inflammasome Sensing of Bacterial Pathogens Type I interferons are integral to host innate and adaptive defenses against infectious organisms. Type I interferons are known to inhibit NLR P3-dependent IL-1b responses to DAMPs such as urate crystals and ATP, primarily by inhibiting the transcription of pro-IL-1b (Guarda et al., 2011) . However, a growing number of recent studies have unveiled a requirement for type I interferon signaling in enabling inflammasome activation by bacteria (Broz et al., 2012; Case et al., 2013; Casson et al., 2013; Henry et al., 2007; Jones et al., 2010; Man et al., 2015a; Meunier et al., 2014; Pilla et al., 2014; Rathinam et al., 2012b) . During Gram-negative bacterial infections, type I interferon signaling sensitizes immune cells for cytosolic LPS and DNA sensing by enhancing the expression of the intracellular LPS receptor (caspase-11), GBPs, and potentially additional molecules ( Figure 2 ) (Man et al., 2015a; Meunier et al., 2014 Meunier et al., , 2015 Rathinam et al., 2012b) . Mechanistically, GBPs target vacuolar and cytosolic bacteria and compromise the integrity of bacterial cells in a yet-to-be identified manner, thus exposing the microbial ligands LPS and DNA to caspase-11 and AIM2, respectively. GBPs have also been shown to regulate the entry of LPS into the cytosol by as yet poorly defined mechanisms (Pilla et al., 2014) . In summary, emerging data point to the importance of type I interferon signaling in inflammasome surveillance of bacterial infections.
Additional Roles of Inflammasome Complexes
Although the ability of inflammasomes to control caspase-1-dependent maturation of IL-1b and IL-18 as well as cell death is well appreciated, several additional, much less well-characterized effector functions of inflammasome complexes have also been described.
Unconventional Protein Secretion
Unlike most secretory proteins that contain amino-terminal or internal signal peptides to direct their sorting to the endoplasmic reticulum (ER) and subsequent release through the Golgi secretory pathway, IL-1b, a leaderless cytoplasmic protein, is secreted from cells by poorly defined mechanisms. This ER/Golgi-independent mechanism termed ''unconventional protein secretion'' was shown to be dependent on caspase-1 activation. Although IL-1b cleavage and release are tightly coupled events, whether caspase-1 plays a direct role in driving IL-1b release or release occurs as a result of compromised membrane integrity that precedes cell death is still unclear. Early studies utilized mass spectrometry-based secretome analysis, which demonstrated the caspase-1-mediated secretion of several leaderless proteins, including caspase-1 itself as well as IL-1b, IL-1a, HMGB1, and fibroblast growth factor 2 (FGF2), several of which are not substrates of caspase-1 itself (Keller et al., 2008) . The mechanisms and molecular components of this unconventional protein secretion pathway are still unclear. Multiple mechanisms have been proposed to facilitate the release of these leaderless proteins (Monteleone et al., 2015) . IL-1b and caspase-1 are proposed to translocate into secretory lysosomes, a compartment that has features of both lysosomes and secretory granules. Upon activation of inflammasome complexes, secretory lysosomes then fuse with plasma membranes, resulting in the release of mature IL-1b and caspase-1 into the extracellular space. Alternative studies have suggested that IL-1b and caspase-1 are shed in microvesicles and released to the extracellular side of the plasma membrane or packed into multi-vesicular bodies and released in exosomes (Nickel and Rabouille, 2009 ). More recent studies have defined the importance of autophagy in the unconventional secretion of IL-1b (Dupont et al., 2011) . Autophagy induction cooperates with Golgi reassembly stacking proteins (GRASP) and Rab8a (a GTPase controlling post-Golgi polarized sorting and exocytosis) to regulate IL-1b secretion. Another Rab GTPase family member, Rab39a, is itself a substrate of caspase-1 and also plays a role in IL-1b secretion (Becker et al., 2009) . All of these studies have analyzed secretory pathways downstream of caspase-1 in different cell types. It is possible that different mechanisms of unconventional secretion are operational in different cellular contexts. The recent discovery of gasdermin D as the executioner of pyroptotic cell death argues against a role for vesicle-and autophagy-dependent secretory pathways and The canonical inflammasome pathway is triggered by multiple pathogens and inflammatory agents. Nek7 is recruited to the NLRP3 complex, which recruits pro-caspase-1 monomers through the adaptor protein ASC. Caspase-1 processes the pro-inflammatory cytokine pro-IL-1b to generate mature IL-1b, which is presumably released by cell lysis during pyroptosis. Caspase-1 also initiates pyroptosis by cleaving gasdermin D. Murine caspase-11 (caspase-4 and caspase-5 in humans) oligomerizes upon binding with cytosolic LPS and becomes active. Active caspase-11 cleaves gasdermin D to drive pyroptosis and NLRP3 inflammasome-dependent cleavage of caspase-1 through an unknown mechanism. instead favors a model whereby gasdermin-D-dependent membrane rupture leads to IL-1b release. Indeed, gasdermin D-deficient cells fail to undergo membrane rupture and as a result cannot release IL-1b to the extracellular space despite having the ability to activate caspase-1 and induce maturation of IL-1b intracellularly (He et al., 2015; Kayagaki et al., 2015; Shi et al., 2015) . Future studies are required to fully clarify and distinguish among these mechanisms. Inflammasome Induction of Eicosanoids An array of lipid molecules collectively known as lipid mediators are pivotal regulators of inflammatory responses (Shimizu, 2009 ). Eicosanoids, which comprise various lipid species including the well-studied prostaglandins, thromboxane, hydroxyeicosatetraenoic acid (HETEs), and leukotrienes, are bioactive molecules derived from membrane lipids. Eicosanoids play key roles in diverse homeostatic and pathological processes, such as increasing vascular permeability and leukocyte recruitment (Dennis and Norris, 2015) . Eicosanoid synthesis has been identified as a direct outcome of inflammasome activation (von Moltke et al., 2012) (Figure 3) ; active caspase-1 generated by multiple inflammasomes such as NAIP/NLRC4 and NLRP1 stimulates rapid eicosanoid synthesis by the activation of cytosolic phospholipase A2. Surprisingly, this function of caspase-1 is independent of IL-1b, IL-18, and pyroptosis, the classic outcomes of inflammasome activation. Instead, active caspase-1 drives acute Ca 2+ influx via membrane pore formation. Ca 2+ influx in turn activates cytosolic phospholipase A2 (cPLA2) to generate arachidonic acid from membrane phospholipids. Arachidonic acid is ultimately converted to prostaglandins and thromboxanes by cyclooxygenases-1 (COX-1) and COX-2 and HETEs and leukotrienes by lipoxygenases (12/15-LOX and 5-LOX). This caspase-1-mediated synthesis of eicosanoids, particularly PGE2, elicits a rapid and robust vasodilation, fluid loss from blood, hemoconcentration, diarrhea, and hypothermia, culminating in the death of mice. Consistently, mice lacking caspase-1, cPLA2, and Cox-1 are protected. Another unique feature of this ''eicosanoid storm'' is its cellular origin; although inflammasome-mediated maturation of cytokines and cell death are common to multiple cell types, only resident peritoneal macrophages but not thioglycollate-elicited or bone marrow-derived macrophages are equipped with the capability to synthesize and secrete substantial amounts of prostaglandins and leukotrienes in response to inflammasome triggers in vivo and ex vivo. It is believed that the high-steady-state level expression of Cox1, Alox12/15, and Alox5 (enzymes involved in eicosanoid synthesis) in resident peritoneal macrophages likely accounts for these effects. Eicosanoid synthesis is also stimulated by the non-canonical caspase-11 inflammasome. The eicosanoid storm generated during caspase-11-mediated endotoxin shock contributes to host mortality, and the pharmacological inhibition of Cox-1 markedly improves host survival (Hagar et al., 2013) . A localized, transient, and controlled wave of eicosanoid production may be beneficial for the host to limit and eliminate foci of infection by recruiting phagocytic cells and complement components. On the other hand, sustained and systemic production of proinflammatory eicosanoids would be detrimental to the host. Although the synthesis of proinflammatory eicosanoids as an output of inflammasome signaling is evident, whether caspase-1 activation can also stimulate the production of anti-inflammatory and proresolving lipid mediators is not yet known. Nonetheless, the eicosanoid storm downstream of inflammatory caspases expands the means by which inflammasomes can propagate inflammation and thus should be taken into consideration in developing new treatment measures for inflammatory disorders.
Autophagy and Inflammasomes
Several recent studies have highlighted important cross-talk between inflammasome activation and autophagy. Autophagy is a basic catabolic process that recycles cytosolic macromolecular Gram-negative bacterial infections lead to the activation of TLR4-TRIF-type I IFN pathway, which induces the expression of caspase-11 and GBPs. Type I interferon induction by Francisella via cGAS upregulates the expression of GBPs. Type I interferon signaling aids in the cytosolic access of LPS and DNA, leading to the activation of caspase-11 and AIM2, respectively. structures and organelles . A multifaceted role for autophagy in the negative regulation of inflammasome activation is well established (Rathinam et al., 2012a) . Autophagy of mitochondria, mitophagy, limits NLRP3 inflammasome activation by targeting damaged mitochondria for removal, and deficiency of any of the key factors, such as LC3, Beclin, Ulk1, or Receptor interacting protein kinase 2 (RIP2), involved in this process enhances caspase-1 activation (Levine et al., 2011; Lupfer et al., 2013; Nakahira et al., 2011; Rathinam et al., 2012a) . Furthermore, autophagy mediates the removal of macromolecular inflammasome complexes to restrain caspase-1 activation (Shi et al., 2012) . Interestingly, the antagonism between autophagy and inflammasomes is mutual; inflammasomes also display an inhibitory effect on autophagy itself. During Shigella flexneri infection of macrophages, NLRC4-mediated activation of caspase-1 suppresses autophagy and autophagosome formation (Suzuki et al., 2007) . Similarly, TLR4-and TRIF-dependent stimulation of autophagy by Pseudomonas aeruginosa is also suppressed by the NLRC4 inflammasome (Jabir et al., 2014) . Caspase-1 activated by the NLRC4 inflammasome cleaves TRIF at aspartic acid residues 286 (ILPDA) and 292 (AAPDT). Because TRIF is required for autophagy induction during Pseudomonas infection, caspase-1-mediated inactivation of TRIF downregulates autophagy. The suppression of autophagy by the inflammasome appears to favor P. aeruginosa replication in mice. Like the NLRC4 inflammasome, AIM2 and NLRP3 inflammasomes also negatively regulate autophagy. Active caspase-1 generated by the AIM2 and NLRP3 inflammasomes inactivates parkin, a key protein involved in mitophagy, by cleaving it at an aspartic acid residue (aa126), leading to the accumulation of damaged mitochondria (Yu et al., 2014) . Autophagy is classically considered as a salvaging process, whereas inflammasome activation invariably leads to the rapid demise of the cell. Therefore, the balance between autophagy and inflammasome activity during sterile inflammation and infection perhaps guides a cell's decision to survive or die.
An exception to this suppressive effect of inflammasomes on autophagy is the NLRP6 inflammasome in the intestine. The NLRP6 inflammasome is important in maintaining intestinal homeostasis (Elinav et al., 2011) . Microbial metabolites such as taurine regulate the activation of the NLRP6 inflammasome, which in turn shapes the composition of the microbiome, favoring a beneficial microbiome interface at the gut mucosa (Levy et al., 2015) . Autophagy is an effector mechanism that is downstream of the NLRP6 inflammasome and contributes to its homeostatic function. Specifically, the NLRP6 inflammasome expressed in goblet cells promotes autophagy, which ensures optimal mucus secretion in the gut by facilitating goblet cell mucin granule exocytosis (Wlodarska et al., 2014 ). The precise molecular basis of NLRP6 inflammasome regulation of autophagy, particularly if it is direct, is yet to be determined. Nonetheless, these findings demonstrate that the relationship between inflammasomes and autophagy is not universally antagonistic but can be specific to cell type, tissue, context, and potentially inflammasome type.
Regulation of Phagosome Maturation by Inflammasomes
Phagocytosis is one of the most important anti-microbial defense mechanisms. The anti-microbial function of the phagosome-vesicles containing phagocytosed cargo-is conferred by the pH-sensitive degradative enzymes derived upon fusion with lysosomes. This process termed phagosome maturation relies on the acidification of phagosomes as they move from the plasma membrane toward lysosomes. The lowering of pH in the phagosomal lumen favors the activation of proteolytic and lipolytic enzymes. Phagosome acidification and maturation is a complex process involving delicate spatio-temporal interactions among several cellular proteins, including small GTPases. A new addition to this growing list of regulators of phagosome maturation are inflammasomes (Sokolovska et al., 2013) . The acidification of phagosomes with the cargo of Gram-positive bacteria such as Staphylococcus aureus and Group B streptococcus requires NLRP3 inflammasome activation. In this context, the activation of caspase-1 by the NLRP3 inflammasome 
. Novel Functions of Inflammasomes
Inflammasome activation leads to the proteolytic activation of IL-1b, IL-18, and gasdermin D; the latter triggers inflammatory cell death, pyroptosis. In addition, caspase-1 activated by inflammasomes cleaves an additional but partially known set of substrates, such as Nox2, TRIF, and parkin, and thereby regulates a multitude of processes such as eicosanoid synthesis, phagosomal acidification, autophagy, glycolysis, and lipid metabolism in an IL-1 cytokine-and pyroptosis-independent fashion. blue and orange rectangles represent the canonical and noncanonical functions of inflammasomes. Black text outside the rectangles indicates caspase-1 substrates.
occurs immediately upon phagocytosis of S. aureus. Such a rapid activation of NLRP3 seems to be driven by events associated with the phagocytic process itself, including but not limited to the production of reactive oxygen species (ROS). Interestingly, the active caspase-1 molecule accumulates on phagosomes containing Gram-positive bacteria but not on phagosomes where the cargo is latex beads. This cargo-dependent accrual of active caspase-1 on phagosomes is important for subsequent lowering of the pH in the phagosomal lumen. Active caspase-1 targets the phagocyte NADPH oxidase (NOX2) complex, which assembles on the phagosomal membrane and generates superoxide anions in the phagosomal lumen, causing alkalinization. Caspase-1 proteolytically inactivates one or more components, such as gp91 and Rac1, of the transmembrane NOX2 complex and thus accelerates the rate of acidification of phagosomes. Consequently, the NLRP3 inflammasome facilitates anti-microbial activities of the phagosome, leading to effective bacterial killing. Furthermore, the enhancement of the degradative capacity of phagosomes by the NLRP3-caspase-1 axis adversely impacts antigen cross-presentation and CD8 T cell activation.
Inflammatory caspases regulate phagosome maturation at more than one stage. Caspase-11 in mice and its orthologs in humans (caspase-4 and caspase-5) mediate the fusion of Legionella pneumophila-containing phagocytic vacuoles with lysosomes by regulating the F-actin network assembly (Akhter et al., 2012) . Surprisingly, caspase-11 deficiency does not impact the trafficking of phagosomes with non-pathogenic bacteria such as E. coli DH5a. L. pneumophila actively interferes with endosomal trafficking via its type IV secretion system effector proteins to prevent fusion of endosomes with lysosomes. Therefore it can be speculated that caspase-11 aids the host in overcoming such bacterial evasion mechanisms to ensure effective killing of intracellular bacteria. Caspase-1 Modulation of Metabolism An exciting theme emerging from the last decade of research is that inflammation and metabolism are more intimately linked than previously thought. Although recent evidence indicates that the metabolic status of a cell is a critical determinant of the type and magnitude of the inflammatory response (O'Neill and Hardie, 2013), chronic inflammation is a risk factor underlying several metabolic disorders such as obesity and diabetes. Inflammasomes modulate carbohydrate and lipid metabolism via several mechanisms. The cytokine output of inflammasomes, specifically IL-1b, is well documented to play critical roles in diabetes and atherosclerosis. Nonetheless, inflammasomes control metabolic processes in an IL-1 cytokine-independent manner. An in vitro caspase-1 cleavage assay combined with the proteomic approach to identify substrates of caspase-1 revealed multiple proteins in the glycolysis pathway, including aldolase, triose-phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a-enolase, and pyruvate kinase, as caspase-1 substrates (Shao et al., 2007) . Indeed, several of these proteins were cleaved by caspase-1 during infection with Salmonella enterica serovar Typhimurium, which activates the NLRC4 inflammasome. As a result, the glycolytic rate was blunted in macrophages with active inflammasomes. This perhaps plays a role in making the intracellular microenvironment less hospitable for pathogens, such as Salmonella, that persist inside the cell. Even more importantly, the processing or degradation of GAPDH, aldolase, and a-enolase was observed in diaphragm muscles of mice during endotoxic shock, which could compromise the contractibility of respiratory muscles and contribute to the respiratory failure in septic shock patients. These findings highlight from a therapeutic perspective the critical point that targeting the IL-1 family of cytokines alone during inflammasomedriven disorders such as sepsis might not be sufficient for a beneficial effect.
In addition to modulating glycolysis, inflammasomes also regulate lipid homeostasis. Caspase-1 activation by a bacterial pore-forming toxin, namely aerolysin in chinese hamster ovary (CHO) cells, leads to the activation of sterol regulatory element-binding proteins (SREBPs). SREBPs are ER-resident proteins that become active in cholesterol-poor conditions, driving the transcription of cholesterol and fatty-acid biosynthetic genes (Gurcel et al., 2006) . The stimulation of SREBPs by caspase-1 via an unknown mechanism leads to lipid biosynthesis, which eventually contributes to the repair of membrane damage induced by aerolysin. Triglyceride (TG) metabolism is another aspect of lipid homeostasis regulated by caspase-1. Caspase-1 was previously shown to play a role in TG absorption in the intestine and their production in the liver (van Diepen et al., 2013) . However, recent evidence suggests that caspase-1 facilitates the clearance of triglycerides from the plasma during fasting conditions as well as after the uptake of a lipid bolus (Kotas et al., 2013) . As a result, lipid metabolism is substantially dysregulated in caspase-1-deficient mice. Although caspase-1 activation in these conditions is driven by the NLRP3 inflammasome, the effect of caspase-1 on TG metabolism is independent of IL-1 and IL-18 cytokines, again implying the involvement of yet-tobe-identified mechanism(s).
Inflammasome Complex-Independent Functions of NLR/ALR Proteins
Although all of the mechanisms described above are novel functions of inflammasome complexes, certain inflammasome components also appear to have biological functions that are independent of their capacity to form inflammasome complexes and to activate caspase-1 and IL-1b/IL-18. Specifically, AIM2, NLRP3, NLRP6, and NLRP12 have all been linked to biological responses that appear to be independent of the ability of these proteins to engage ASC/caspase-1 (Figure 4 ). AIM2 Control of Tumorigenesis AIM2, which forms a caspase-1-activating inflammasome in response to cytosolic DNA, has recently been linked to prevention of colorectal cancer (Man et al., 2015b; Wilson et al., 2015) . It was known for some time that mutations in AIM2 were associated with colorectal cancer in humans. Two recent studies demonstrated that Aim2-deficient mice had increased susceptibility to colonic carcinogenesis. Unexpectedly, this tumor-suppressive effect of AIM2 was independent of its inflammasome complex-forming capacity and inflammasomeassociated cytokines. Rather, the mechanism driving AIM2-dependent protection against tumorigenesis was dependent on the ability of AIM2 to suppress proliferation of intestinal epithelial cells. Furthermore, AIM2 limits DNA-dependent protein kinase-mediated activation of Akt, a critical regulator of cell survival and proliferation . In addition, the gut microbiota seems to also play a role in the hyper-susceptibility of Aim2-deficient mice to colorectal tumorigenesis (Man et al., 2015b) . Together, these findings reveal an important role for AIM2 in determining susceptibility to colorectal cancer and highlight inflammasome-independent roles for this DNA-binding protein.
NLRP3, NLRP6, and NLRP12 Regulation of Innate and T Cell Immunity
An inflammasome-independent function has also recently been proposed for the NLRP3 inflammasome (Bruchard et al., 2015) . NLRP3 was found to be expressed in differentiated T helper cell subsets and specifically control Th2 cell differentiation. Unlike myeloid cells where NLRP3 is cytosolic, NLRP3 is localized to the nucleus in T cells and lacks inflammasome-forming capabilities. Rather, NLRP3 interacts with the transcription factor IRF4 and binds to the promoter regions of Th2 cytokine genes to induce their expression. Consistent with a role for NLRP3 in coordinating Th2 cell target gene expression, NLRP3 regulates asthma and Th2 cell-dependent control of melanoma growth (Bruchard et al., 2015) .
NLRs also regulate signaling pathways via inflammasome-independent means. For example, NLRP6 was shown to negatively regulate mitogen-activated protein kinase (MAPK) and the canonical NF-kB pathway in response to Toll-like receptor, but not NOD1/2 signaling. Accordingly, NLRP6 reduced the production of NF-kB-and MAPK-dependent cytokines and chemokines, leading to enhanced susceptibility to infection with bacterial pathogens . Most recently, NLRP6 has also been shown to function as a sensor for enteric viruses . NLRP6 binds viral RNA via RNA helicase DHX15, triggering the expression of type I/III interferons and interferon-stimulated genes (ISGs). Consequently, NLRP6 contributed to the control of encephalomyocarditis virus and norovirus infection of the gastrointestinal tract.
Several studies have also defined anti-inflammatory functions for NLRP12 that are independent of inflammasome functions. NLRP12 dampens NF-kB and ERK activation, in the absence of which mice are highly susceptible to colon inflammation and colorectal tumor development (Allen et al., 2012; Zaki et al., 2011) . NLRP12 also limits non-canonical NF-kB signaling in osteoclast precursors and downregulates osteoclastogenesis, thus altering bone homeostasis (Krauss et al., 2015) . NLRP12 has also been shown to function in neutrophils as a negative regulator of cell migration in vitro (Zamoshnikova et al., 2016) . Finally, an unexpected role for NLRP12 as a negative regulator of T cell-mediated IL-4 production has also been defined (Lukens et al., 2015) . Taken together, all of these emerging data reveal much broader roles for NLR and ALR members in different immune cells beyond inflammasome activation.
Conclusions and Future Directions
A solid body of evidence from in vitro and in vivo studies over the last several years has clearly positioned IL-1b, IL-18, as well as pyroptotic cell death as central mediators of inflammasomedriven biological responses. Recent studies, however, have also provided compelling evidence for the existence of additional effector mechanisms downstream of inflammasome complexes. In addition, new functions for some NLRs and AIM2 have been described, which broadens our understanding of the functions of these proteins. These novel pathways as described in this Review play crucial roles not only in infection and sterile inflammatory conditions but also in controlling cellular homeostasis. Such a diversification of inflammasome outcomes could be due to the many substrates available for the inflammatory caspases. The limited number of currently known substrates of caspase-1 and -11 could very well be the ''tip of the iceberg.'' Therefore, the identification and characterization of novel inflammasome substrates as well as further understanding of the inflammasome-independent roles of NLRs and ALRs would be of great biological as well as therapeutic interest as it would guide the design of the next generation of drugs to treat infectious and inflammatory diseases.
